| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9154875 | American Heart Journal | 2005 | 8 Pages |
Abstract
A preprocedural hyperglycemia is associated with a higher rate of MACE, regardless of the use of abciximab, in diabetic patients undergoing elective coronary stenting.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Leonardo MD, Giovanni MD, Monia MD, Carlo MD, Francesco MD,